{"id":"https://openalex.org/W2505259592","doi":"https://doi.org/10.1158/1538-7445.am2016-1293","title":"Abstract 1293: JQ1 sensitivity of patient-derived xenograft models of cholangiocarcinoma","display_name":"Abstract 1293: JQ1 sensitivity of patient-derived xenograft models of cholangiocarcinoma","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2505259592","doi":"https://doi.org/10.1158/1538-7445.am2016-1293","mag":"2505259592"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-1293","doi":"https://doi.org/10.1158/1538-7445.am2016-1293","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-1293","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028692847","display_name":"Aubrey Lynn Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aubrey L. Miller","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089931659","display_name":"Patrick L. Garcia","orcid":"https://orcid.org/0000-0001-8721-6434","observed_orcids":["https://orcid.org/0000-0001-8721-6434"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick L. Garcia","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051944730","display_name":"Tracy L. Gamblin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracy L. Gamblin","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029597544","display_name":"Xiangqin Cui","orcid":"https://orcid.org/0000-0003-0621-9313","observed_orcids":["https://orcid.org/0000-0003-0621-9313"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiangqin Cui","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274677","display_name":"James E. Bradner","orcid":"https://orcid.org/0000-0002-2718-4415","observed_orcids":["https://orcid.org/0000-0002-2718-4415","https://orcid.org/0000-0003-1422-5318"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James E. Bradner","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA","1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035724058","display_name":"Eddy Shih-Hsin Yang","orcid":"https://orcid.org/0000-0002-6450-2638","observed_orcids":["https://orcid.org/0000-0002-6450-2638"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eddy S. Yang","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;","2Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078320545","display_name":"Karina Jin Yoon","orcid":"https://orcid.org/0000-0002-0830-571X","observed_orcids":["https://orcid.org/0000-0002-0830-571X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karina J. Yoon","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"1293","last_page":"1293"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9340000152587891},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":1.0},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cell-cycle-genes","display_name":"cell cycle genes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.8669999837875366},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.7440000176429749},{"id":"https://openalex.org/keywords/nanostring","display_name":"NanoString","score":0.5619999766349792},{"id":"https://openalex.org/keywords/gemcitabine-cisplatin","display_name":"gemcitabine plus cisplatin","score":0.7239999771118164},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.531000018119812},{"id":"https://openalex.org/keywords/biliary-tract-cancer","display_name":"biliary tract cancer","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.7420670390129089},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6805902719497681},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6121781468391418},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.5502908825874329},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.5330103039741516},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5016772747039795},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47318196296691895},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.433987557888031},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42367786169052124},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.410367876291275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40691515803337097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39313745498657227},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14993801712989807},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14285701513290405},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-1293","doi":"https://doi.org/10.1158/1538-7445.am2016-1293","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-1293","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8100000023841858}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2567596598","https://openalex.org/W2770190286","https://openalex.org/W2955909455","https://openalex.org/W2886435524","https://openalex.org/W1539621112","https://openalex.org/W2594738913","https://openalex.org/W2016266320","https://openalex.org/W2889166410","https://openalex.org/W7128902720","https://openalex.org/W2920493020"],"abstract_inverted_index":{"Abstract":[0],"Cholangiocarcinoma":[1],"(CCA)":[2],"is":[3,75,90,202,294],"a":[4,246],"lethal":[5],"malignancy":[6],"arising":[7],"from":[8,221],"cholangiocytes":[9],"in":[10,113,130,177,188,207,249,254,267,296,327],"any":[11],"part":[12],"of":[13,19,42,94,116,123,140,156,172,190,219,243,286,292,311,323,325,357,361,366,371],"the":[14,24,28,54,62,79,91,98,153,170,173,191,205,241,250,255,309,321,367,372],"biliary":[15],"tree.":[16],"The":[17,40,120],"incidence":[18],"CCA":[20,141,157,164,178,185,213,328],"has":[21,106,125,148],"been":[22,107,126,149],"on":[23],"rise":[25],"worldwide,":[26],"and":[27,30,49,68,100,145,224,270,289,314],"prognosis":[29],"clinical":[31],"outcome":[32,89],"have":[33],"remained":[34],"essentially":[35],"unchanged":[36],"for":[37,72,204,375],"30":[38],"years.":[39],"majority":[41],"patients":[43,74],"are":[44],"diagnosed":[45],"at":[46,128],"late":[47],"stage,":[48],"surgery":[50],"continues":[51],"to":[52,81,109,132,135,151,163,209,245,320],"be":[53],"only":[55],"cure.":[56],"Patients":[57],"receive":[58],"systemic":[59],"chemotherapy":[60],"with":[61],"first-line":[63],"combination":[64],"therapy":[65],"comprising":[66],"gemcitabine":[67],"cisplatin.":[69],"Median":[70],"survival":[71],"these":[73],"<12":[76],"months,":[77],"emphasizing":[78],"need":[80],"improve":[82],"current":[83],"treatment.":[84],"A":[85],"step":[86],"toward":[87],"improving":[88],"pre-clinical":[92],"evaluation":[93],"novel":[95],"therapeutics.":[96],"Recently":[97],"bromodomain":[99],"extra-terminal":[101],"domain":[102],"(BET)":[103],"inhibitor":[104,175],"JQ1":[105,124,176,183,210,225,239,326,355],"shown":[108,150],"suppress":[110],"tumor":[111,118,186],"growth":[112,187],"preclinical":[114],"models":[115,252,360],"multiple":[117],"types.":[119],"therapeutic":[121],"effect":[122],"attributed,":[127],"least":[129],"part,":[131],"its":[133,146],"ability":[134],"inhibit":[136],"c-Myc":[137,144,161,244],"expression.":[138],"95%":[139],"tumors":[142,220],"express":[143],"down-regulation":[147],"reduce":[152],"invasive":[154],"potential":[155],"cells,":[158],"suggesting":[159],"that":[160,238,263,308],"contributes":[162],"phenotype.":[165],"Our":[166,235],"lab":[167],"recently":[168],"evaluated":[169],"efficacy":[171],"BET":[174],"patient-derived":[179,358],"xenograft":[180,359],"mouse":[181],"models.":[182,193],"suppressed":[184],"2":[189],"3":[192],"To":[194],"determine":[195],"gene":[196,264],"products":[197,265],"whose":[198],"upregulation":[199],"or":[200],"downregulation":[201],"responsible":[203],"differences":[206],"sensitivity":[208,356],"among":[211],"our":[212],"models,":[214],"we":[215],"generated":[216],"expression":[217,242,303],"profiles":[218],"vehicle":[222],"control":[223],"treated":[226],"mice":[227],"using":[228],"NanoString":[229],"technology":[230],"(nCounter":[231],"PanCancer":[232],"Pathways":[233],"panel).":[234],"data":[236,260],"demonstrate":[237],"inhibited":[240],"greater":[247],"extent":[248],"sensitive":[251],"than":[253],"insensitive":[256],"model.":[257],"Expression":[258],"array":[259],"showed":[261],"further":[262],"involved":[266,295],"cell":[268,312],"cycle":[269,313],"DNA":[271,297,315],"repair":[272,316],"pathways":[273],"were":[274,282],"also":[275],"decreased":[276],"by":[277],"JQ1.":[278],"Of":[279],"particular":[280],"interest":[281],"two":[283],"transcriptional":[284],"targets":[285],"c-Myc,":[287],"Chk1":[288],"BRCA2,":[290],"each":[291],"which":[293],"damage":[298],"response.":[299],"Immunohistochemistry":[300],"staining":[301],"confirmed":[302],"profile":[304],"analyses.":[305],"We":[306],"conclude":[307],"inhibition":[310],"genes":[317],"may":[318],"contribute":[319],"mechanism":[322],"action":[324],"tumors.":[329],"Citation":[330],"Format:":[331],"Aubrey":[332],"L.":[333,336,339],"Miller,":[334],"Patrick":[335],"Garcia,":[337],"Tracy":[338],"Gamblin,":[340],"Leona":[341],"N.":[342],"Council,":[343],"Xiangqin":[344],"Cui,":[345],"James":[346],"E.":[347],"Bradner,":[348],"Eddy":[349],"S.":[350],"Yang,":[351],"Karina":[352],"J.":[353],"Yoon.":[354],"cholangiocarcinoma.":[362],"[abstract].":[363],"In:":[364],"Proceedings":[365],"107th":[368],"Annual":[369],"Meeting":[370],"American":[373],"Association":[374],"Cancer":[376,387],"Research;":[377],"2016":[378],"Apr":[379],"16-20;":[380],"New":[381],"Orleans,":[382],"LA.":[383],"Philadelphia":[384],"(PA):":[385],"AACR;":[386],"Res":[388],"2016;76(14":[389],"Suppl):Abstract":[390],"nr":[391],"1293.":[392]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-08-23T00:00:00"}